Infrared Radiation: A Non-Invasive Approach to Cholesterol Measurement

Year : 2024 | Volume : 14 | Issue : 03 | Page : 28 34
    By

    Heba Qasim Zaghir,

  1. Researcher, Department Biomedical Engineering, University of Thi-Qar, , Iraq

Abstract

Cholesterol levels and Diabetes have become prevalent worldwide. People who are physically disabled or unresponsive need to have their glucose and cholesterol levels constantly checked because it is hard to get accurate readings through invasive procedures or blood samples. Based on the proposed model, Hyperglycemia and Cholesterol amounts might be found without touching or taking blood specimens. The Arduino UNO and basic infrared sensors are used to make this happen. Power LED sockets measure cholesterol and glucose while the patient’s palms are on an infrared detector. The glucose and cholesterol levels of diabetic patients and pregnant women must be monitored regularly. Cardiovascular disease, which results in stroke and heart attack, is caused by the minimum level of cholesterol in the blood. Depending on how the energy from LED light bounces off of bloodstream cells, the Arduino UNO receives the values. Glucose and Cholesterol values are computed with the assistance of the Arduino UNO program. Furthermore, calculating Haemoglobin, LDL, and HDL values is an additional benefit. The proposed model is more cost-effective and saves more time. By utilizing the Internet of Things (IoT), this project can be further developed by transmitting virtual measurements. Nowhere else has a non-invasive technique for measuring glucose and cholesterol been used, which shows how new and different this approach is. No matter what, the model works well and is not affected by outside interruptions like various forms of light.

Keywords: Non-invasive monitoring, cholesterol, medical diagnostics, innovative healthcare solutions, diabetic patients, infrared sensors.

[This article belongs to Research & Reviews: A Journal of Medicine ]

How to cite this article:
Heba Qasim Zaghir. Infrared Radiation: A Non-Invasive Approach to Cholesterol Measurement. Research & Reviews: A Journal of Medicine. 2024; 14(03):28-34.
How to cite this URL:
Heba Qasim Zaghir. Infrared Radiation: A Non-Invasive Approach to Cholesterol Measurement. Research & Reviews: A Journal of Medicine. 2024; 14(03):28-34. Available from: https://journals.stmjournals.com/rrjom/article=2024/view=182254


References

  1. Mattina A, Giammanco A, Giral P, Rosenbaum D, Carrié A, Cluzel P, Gallo A.  Polyvascular subclinical atherosclerosis in familial hypercholesterolemia: The role of cholesterol burden and gender. Nutrition, Metabolism and Cardiovascular Diseases. 2019;29(10):1068–1076.
  2. Watts GF, Catapano AL, Masana L, Zambon A, Pirillo A, Tokgözoğlu L. Hypercholesterolemia and cardiovascular disease: focus on high cardiovascular risk patients. Atherosclerosis Supplements. 2020 Dec 1;42:e30–4.
  3. Masana L, Zamora A, Plana N, Comas-Cufí M, Garcia-Gil M, Martí-Lluch R, Ponjoan A, Alves-Cabratosa L, Elosua R, Marrugat J, Dégano IR. Incidence of cardiovascular disease in patients with familial hypercholesterolemia phenotype: analysis of 5 years follow-up of real-world data from more than 1.5 million patients. J cln med . 2019 Jul 23;8(7):1080.
  4. Ji X, Leng XY, Dong Y, Ma YH, Xu W, Cao XP, Hou XH, Dong Q, Tan L, Yu JT. Modifiable risk factors for carotid atherosclerosis: a meta-analysis and systematic review. Annl translatmed. 2019 Nov;7(22).
  5. Trinder M, Li X, DeCastro ML, Cermakova L, Sadananda S, Jackson LM, Azizi H, Mancini GJ, Francis GA, Frohlich J, Brunham LR. Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia. J Amer Colg Cardio. 2019 Jul 30;74(4):512–22.
  6. Trinder M, Francis GA, Brunham LR. Association of monogenic vs polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease. JAMA cardiology. 2020 Apr 1;5(4):390–9.
  7. Linton MF, Yancey P G, Davies S S, Jerome, W G Linton, E.F, Song W.L,  Vickers, K C . The role of lipids and lipoproteins in atherosclerosis. Endotext. 2019.
  8. Schade DS, Cavanaugh B, Ramo B, Eaton RP. The application of the LDL principle. Wld Jof Cardiovascular Diseases. 2016 May.20;6(5):109–25.
  9. Pirillo A, Norata GD, Catapano AL. Beyond LDL-C levels, does remnant cholesterol estimation matter?. Europ J Prevt. Cardioly. 2020 Jul;27(10):1088–90.
  10. Masic, Dznan. Lipids and emerging cardiovascular-and inflammation-related proteins in early, treatment-naïve rheumatoid arthritis.(2023).
  11. Morin E. Optimizing Synthetic High-Density Lipoprotein Compositions for Modulation of Vascular Inflammation (Doctoral dissertation).
  12. Carson JA, Lichtenstein AH, Anderson CA, Appel LJ, Kris-Etherton PM, Meyer KA, Petersen K, Polonsky T, Van Horn L. Dietary cholesterol and cardiovascular risk: a science advisory from the American Heart Association. 2020 Jan 21;141(3):e39–53.
  13. Jende JM, Groener JB, Rother C, Kender Z, Hahn A, Hilgenfeld T, et al. Association of serum cholesterol levels with peripheral nerve damage in patients with type 2 diabetes. JAMA network open. 2019;2(5):e194798–e194798.
  14. Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia. JAMA cardiology. 2020;5(5):540–548.
  15. Stefanadi, EC, et al. Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients.Diabetology & metabolic syndrome.2018): 1–11.
  16. Pownall HJ, Rosales C, Gillard B K, Gotto Jr AM. High-density lipoproteins, reverse cholesterol transport and atherogenesis. Nat Rev Cardiol. 2021;18(10);712–723.
  17. Forsyth AM, Braunmüller S, Wan J, Franke T, Stone HA. The effects of membrane cholesterol and simvastatin on red blood cell deformability and ATP release. Microvasc Res. 2012;83(3):347–351.
  18. Aarts PA, Heethaar R M, Sixma JJ. Red blood cell deformability influences platelets – vessel wall interaction in flowing blood. 1984.
  19. Radosinska J, Vrbjar N. The role of red blood cell deformability and Na, K-ATPase function in selected risk factors of cardiovascular diseases in humans: focus on hypertension, diabetes mellitus and hypercholesterolemia. Physiol Res. 2016; 65.
  20. Niesor EJ, Nader E, Perez A, Lamour F, Benghozi R, Remaley A, et al. Red blood cell membrane cholesterol may be a key regulator of sickle cell disease microvascular complications. Membranes. 2022;12(11):1134.
  21. Kim J, Lee H, Shin S. Advances in the measurement of red blood cell deformability: A brief review. J Cell Biotechnol. 2015;1(1):63–79.
  22. Barshtein G, Pajic-Lijakovic I, Gural A.Deformability of stored red blood cells. Front Physiol. 2021;12:722896.
  23. Michel JB, Martin-Ventura JL. Red blood cells and hemoglobin in human atherosclerosis and related arterial diseases. Int J Mol Sci. 2020;21(18):6756.
  24. Kuhn V, Diederich L, Keller IV TS, Kramer CM, Lückstädt W, Panknin C, et al. Red blood cell function and dysfunction: redox regulation, nitric oxide metabolism, anemia. Antioxidants & redox signaling. 2017;26(13):718–742.
  25. Silbernagel G, Schöttker B, Appelbaum S, Scharnagl H, Kleber ME, Grammer TB, et al. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J. 2013;34(46): 3563–3571.
Regular Issue Subscription Original Research
Volume 14
Issue 03
Received 01/08/2024
Accepted 03/08/2024
Published 11/11/2024
261


My IP

PlumX Metrics